Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

From familial to theranostic germline genetics in breast cancer

Current advances in breast cancer risk assessment: Prime time for a personalised approach?


11 May 2023


From familial to theranostic germline genetics in breast cancer


Population Risk Factor;  Cancer Intelligence (eHealth, Telehealth Technology, BIG Data);  Primary Prevention;  Secondary Prevention/Screening;  Genetic and Genomic Testing;  Statistics;  Genetic Testing and Counselling

Tumour Site

Breast Cancer


Antonis Antoniou


A. Antoniou

Author affiliations

  • University of Cambridge School of Clinical Medicine, Cambridge/GB


This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.